Eradication of MRSA in chronic wounds of outpatients with leg ulcers is accelerated by antiseptic washes - Results of a pilot study

International Journal of Hygiene and Environmental Health

Volumn 213, Issue 2, 2010, Pages 88-92

  Reich Schupke, Stefanie ^a   Warneke, Katharina ^a   Altmeyer, Peter ^a   Stücker, Markus ^a  

^a Vein Centre   (Germany)

Author keywords

Eradication; Leg ulcer; MRSA; Nosocomial infection; Outpatient

Indexed keywords

ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

AGED; ARTICLE; FEMALE; HUMAN; LEG ULCER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; OUTPATIENT; PILOT STUDY; STAPHYLOCOCCUS INFECTION;

AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; FEMALE; HUMANS; LEG ULCER; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OUTPATIENTS; PILOT PROJECTS; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 77649270383     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2010.01.001     Document Type: Article

References (20)

1. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., and Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin. Infect. Dis. 50 (2010) 210-217
2. Buehlmann M., Frei R., Fenner L., Dangel M., Fluckinger U., and Widmer A.F. Highly effective regime for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect. Control Hosp. Epidemiol. 29 (2008) 510-516
3. Climo M.W., Sepkowitz K.A., Zuccotti G., Fraser V.J., Warren D.K., Perl T.M., Speck K., Jernigan J.A., Robles J.R., and Wong E.S. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vanvomycin-resistant Entereococus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit. Care Med. 37 (2009) 1858-1865
4. Coia J.E., Duckworth G.J., Edwards D.I., Farrington M., Fry C., Humphreys H., Mallaghan C., Tucker D.R., for the Joint Working Party of the British Society of Antimicrobial Chemotherapy, and the Hospital Infection Society and the Infection Control Nurses Association. Guidelines for the control and prevention of Methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J. Hosp. Infect. 63S (2006) S1-S44
5. Diller R., Sonntag A.K., Mellmann A., Grevener K., Senninger N., Kipp F., and Friedrich A.W. Evidence for cost reduction based on pre-admission screening in general surgery. Int. J. Hyg. Environ. Health 211 (2008) 205-212
6. Dissemond J., Gerber V., Kramer A., Riepe G., Strohal R., Vasel-BIergans A., and Eberlein T. Praxisorientierte Expertenempfehlung zur Behandlung kritisch kolonisierter und lokal infizierter Wunden mit Polihexanid. Z. Wundheilung 14 (2009) 20-26
7. European Antimicrobial Resistance Surveillance System (EARSS), 2004. Annual Report EARSS - 2003. Bilthoven, The Netherlands: RIVM.
8. Goetghebeur M., Landry P.A., Han D., and Vicente C. Methicillin-resistant Staphylococcus aureus: a public health issue with economic consequences. Can. J. Infect. Dis. Med. Microbiol. 18 (2007) 27-34
9. Goodman E.R., Platt R., Bass R., Onderdonk A.B., Yokoe D.S., and Huang S.S. Impact of an environmental cleaning intervention on the presence of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci on Surfaces in Intensive Care Unit Rooms. Infect. Control Hosp. Epidemiol. 29 (2008) 593-599
10. Kluytmans J., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanism and associated risks. Clin. Microbiol. Rev. 10 (1997) 505-520
11. Kopp B.J., Nix D.E., and Armstrong E.P. Clinical and economic analysis of methicillin-susceptible and resistant Staphylococcus aureus infection. Ann. Pharmacother. 38 (2004) 1377-1382
12. Kresken M., Hafner D., Schmitz F., Wichelhaus T., für die Studiengruppe: Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum,2006. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen und Resistenzen der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2004. Antiinfectives Intelligence, Rheinbach.
13. Kresken M., Hafner D., Schmitz F., Wichelhaus T., für die Studiengruppe: Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum,2003. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen und Resistenzen der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2001. Antiinfectives Intelligence, Bonn.
14. Loeb M., Main C., Walker-Dilks C., Eady A., 2003. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst. Rev., CD003340.
15. Peters G., and on behalf of the Committee for Hospital Hygiene and Infection Prevention at the RKI. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 42 (1999) 954-958
16. Resch A., Wilke M., and Fink C. The cost of resistance: incremental cost of Methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur. J. Health Econ. 10 (2009) 287-297
17. Rietkötter J., Körber A., Grabbe S., and Dissemond J. Eradication of methicillin-resistant Staphylococcus aureus in a chronic wound by a new polyhexanide hydrogel. J. Eur. Acad. Dermatol. Venerol. 21 (2007) 1416-1417
18. Rohr U., Mueller C., Wilhelm M., Muhr G., and Gatermann S. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalised patients with variable site colonization by using Mupirocin in combination with octenidine dihydrochloride. J. Hosp. Infect. 54 (2003) 305-309
19. Trividic M., Gauthier M.L., Sparsa A., Ploy M.C., Mounier M., Boulinguez S., Bedane C., and Bonneblanc J.M. Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome. Ann. Dermatol. Venereol. 129 (2002) 27-29
20. Working Group "Hygiene in Hospital & Practice" of AWMF. Maßnahmen beim Auftreten multiresistenter Erreger. Hyg. Med. 34 7/8 (2009)